Your fact-checks will appear here
Glycopezil is a plant-based dietary supplement marketed to support healthy blood sugar, insulin sensitivity and metabolic balance.
The preponderance of independent reporting describes Glycopezil as a classic online supplement scam: fabricated reviews and endorsements, bait‑and‑switch long‑form ads, aggressive social ads, and repo...
Glycopezil is a plant‑based dietary supplement marketed to support healthy blood sugar, insulin sensitivity and metabolic balance, with vendor sites claiming faster energy, reduced cravings and weight...
There are no publicly available, peer‑reviewed clinical trials that test GlycoPezil (also marketed as Glycopezil/Glyco Pezil) specifically for its effect on hemoglobin A1C according to the reporting p...
Glycopezil is marketed as a multi‑ingredient, plant‑based supplement for “healthy blood sugar” with official websites listing dozens of botanicals and minerals but no transparent, peer‑reviewed clinic...
There is no reliable, independently verified evidence in the provided reporting that GlycoPezil measurably reduces hemoglobin A1C; the product’s official sites make broad blood‑sugar and “reversal” cl...
The available reporting shows no peer‑reviewed randomized trials of GlycoPezil itself; the company's marketing cites clinical-sounding language but provides no public randomized A1C data for the finis...
Three ingredients in GlycoPezil have peer‑reviewed randomized trials or meta‑analyses reporting effects on glycated hemoglobin (A1C): berberine (multiple randomized trials pooled in meta‑analyses show...
Glycopezil, as promoted in viral videos and sales funnels, is not supported by credible scientific evidence to “reverse” diabetes; independent reviewers and scam-watch articles identify it as a classi...
ClinicalTrials.gov is the primary public registry where ongoing and completed clinical trials of dietary supplements are listed and searchable, complemented by domain-specific resources such as PubMed...